NCT06658886 Comparison of the Efficacy of Ultrasound-Guided Corticosteroid Injection and Paraffin Therapy in Carpal Tunnel Syndrome
| NCT ID | NCT06658886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beylikduzu State Hospital |
| Condition | Carpal Tunnel Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 46 participants |
| Start Date | 2024-11-10 |
| Primary Completion | 2025-02-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 46 participants in total. It began in 2024-11-10 with a primary completion date of 2025-02-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to compare the efficacy of paraffin therapy, a physical therapy modality, and ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome, the most common entrapment neuropathy. By doing so, the study will evaluate the effectiveness and feasibility of these two alternative, low-side-effect treatments for managing this frequently encountered condition.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-65. * Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies. * Received either ultrasound-guided corticosteroid injection or paraffin therapy. * Symptoms persisting for at least 3 months. Exclusion Criteria: * Diagnosis of other conditions causing neuropathic symptoms (e.g., polyneuropathy, brachial plexopathy, thoracic outlet syndrome). * History of previous injection or surgery for carpal tunnel syndrome.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06658886 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06658886 currently recruiting?
Yes, NCT06658886 is actively recruiting participants. Contact the research team at bsrn080@gmail.com for enrollment information.
Where is the NCT06658886 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06658886 clinical trial?
NCT06658886 is sponsored by Beylikduzu State Hospital. The trial plans to enroll 46 participants.